Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TXG

+ Watchlist+ Portfolio

10x Genomics, Inc.

Physical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$56.30
52-Week Range
$15.18 – $102.81
Market Cap
$7.51B
P/E (TTM)
—
EPS (TTM)
-0.52
Dividend Yield
0.00%
Advanced Metrics
Price/Book
8.95
PEG Ratio
—
Return on Equity
-8.27%
Return on Assets
-3.93%
Gross Margin
71.96%
Operating Margin
-10.62%
Profit Margin
-10.84%
Current Ratio
5.12
Debt/Equity
0.09
Total Debt
$75.79M
Free Cash Flow
$122.82M
Revenue Growth
1.10%
Earnings Growth
—
Enterprise Value
$7.01B

Market Snapshot

About

10x Genomics develops and manufactures gene sequencing and cell analysis technologies for biological research. The company provides integrated solutions for single-cell analysis, spatial genomics, and in situ analysis, enabling researchers to study complex biological systems at unprecedented resolution.